查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1574994

基于片段的药物发现市场，按产品类型、技术、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Fragment-Based Drug Discovery Market, By Product Type, By Technology, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年基于片段的药物发现市场规模为7.989亿美元，2024年至2032年复合年增长率为11.40%。

基于片段的药物发现市场-市场动态

慢性病发病率飙升推动基于片段的药物发现市场的创新

糖尿病和癌症等慢性疾病的盛行率不断上升，大大推动了基于片段的药物发现（FBDD）市场的创新，促使製药公司寻求更有效的治疗解决方案。根据世界卫生组织 (WHO) 的数据，慢性病占全球死亡人数的 71%，凸显了创新药物发现方法的迫切需求。例如，美国癌症协会报告称，到 2026 年，美国癌症倖存者人数预计将增至近 2,000 万，从而推动对 FBDD 等先进药物发现技术的投资增加。为了应对这些挑战，美国国立卫生研究院 (NIH) 已分配大量资金用于旨在加强药物发现流程并促进学术机构和製药公司之间合作以培育突破性疗法的研究计划。慢性病发病率的激增，加上政府的支持和对先进方法的关注，将透过 FBDD 加速新药的开发，为创新治疗铺平道路。

基于片段的药物发现市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 11.40% 左右的复合年增长率成长

根据产品类型细分，预计 Fragment Screening 将在 2023 年呈现最大市场份额

从技术细分来看，X射线晶体学是2023年的主导类型

从应用细分来看，肿瘤学是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

基于片段的药物发现市场-細項分析：

全球基于片段的药物发现市场根据产品类型、技术、应用、最终用户和地区进行细分。

依产品类型，市场分为四类：片段筛选、片段文库、先导化合物优化和生物物理技术。片段筛选因其在识别潜在候选药物中的关键作用而具有最高优先级，其次是先导化合物优化，这对于精炼先导化合物至关重要。片段库提供必要的资源，而生物物理技术支援验证和表征。

市场依技术分为四大类：X射线晶体学、核磁共振（NMR）光谱、表面等离子共振（SPR）及等温滴定量热法（ITC）。 X 射线晶体学因其确定分子结构的精确性而排名最高，其次是核磁共振 (NMR) 光谱，可详细了解分子相互作用。表面等离子共振 (SPR) 有助于即时结合研究，而等温滴定量热法 (ITC) 则测量相互作用的热力学。

基于片段的药物发现市场-地理洞察

基于片段的药物发现 (FBDD) 市场表现出独特的地理动态，在强大的研究基础设施和生物技术重大投资的推动下，北美处于领先地位。到 2023 年，在美国国立卫生研究院 (NIH) 等致力于推进药物发现技术的措施的支持下，北美将占全球市场份额的 45% 以上。欧洲紧随其后，英国和德国等国家在其製药策略中优先考虑 FBDD，从而加强了学术机构和产业参与者之间的合作； 2022 年，约 2 亿欧元的大量资金将用于创新药物发现计画。于FBDD 的研究中心。拉丁美洲、中东和非洲，儘管较小的市场正在透过提高对 FBDD 好处的认识以及旨在增强当地药物发现能力的战略合作伙伴关係而逐渐扩大。

基于片段的药物发现市场-竞争格局：

基于片段的药物发现 (FBDD) 市场的竞争格局以各个地区的主要参与者为标誌，每个参与者都为创新和市场成长做出了独特的贡献。北美地区占据主导地位，安进（Amgen）和辉瑞（Pfizer）等公司处于领先地位。 2023 年，安进 (Amgen) 报告称，其药物发现管道增加了 30%，这在很大程度上依赖 FBDD 技术。在欧洲，阿斯特捷利康 (AstraZeneca) 和诺华 (Novartis) 等知名企业正在积极推进，阿斯特捷利康 (AstraZeneca) 承诺投资 2 亿欧元用于针对复杂疾病的 FBDD 研究计画就是例证。以药明康德和武田等公司为代表的亚太地区正在获得关注；药明康德于 2022 年扩大了 FBDD 服务，反映出对新型治疗方法不断增长的需求。拉丁美洲正在慢慢崛起，Instituto Butantan 等公司正在探索FBDD 来应对区域健康挑战，而在中东和非洲，当地倡议正在促进合作伙伴关係以增强药物发现能力，展示了解决未满足的医疗需求的协作方法。

最新进展：

2024 年 2 月，布法罗大学的研究人员开发了一种基于片段的药物发现的简化方法，能够更早确定片段设计的可行性。此方法优化了片段的连接，有可能提高药物效力并降低开发成本。

目录

第 1 章：基于片段的药物发现市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 基于片段的药物发现市场片段（按产品类型）
    • 基于片段的药物发现市场片段（按技术）
    • 基于片段的药物发现市场片段（按应用）
    • 最终用户基于片段的药物发现市场片段
    • 基于片段的药物发现市场片段（按国家/地区）
    • 基于片段的药物发现市场片段（按地区）
  • 竞争洞察

第 3 章：基于片段的药物发现主要市场趋势

  • 基于片段的药物发现市场驱动因素
    • 市场驱动因素的影响分析
  • 基于片段的药物发现市场限制
    • 市场限制影响分析
  • 基于片段的药物发现市场机会
  • 基于片段的药物发现市场未来趋势

第 4 章：基于片段的药物发现产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：基于片段的药物发现市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：以片段为基础的药物发现市场格局

  • 2023 年基于片段的药物发现市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：基于片段的药物发现市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 片段筛选
    • 片段库
    • 潜在客户优化
    • 生物物理技术

第 8 章：基于片段的药物发现市场 - 按技术分类

  • 概述
    • 按技术分類的细分市场份额分析
    • X射线晶体学
    • 核磁共振 (NMR) 波谱学
    • 表面等离子共振 (SPR)
    • 等温滴定量热法 (ITC)

第 9 章：基于片段的药物发现市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 肿瘤学
    • 传染病
    • 心血管疾病
    • 神经系统疾病

第 10 章：基于片段的药物发现市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药公司
    • 生技公司
    • 学术及研究机构
    • 合约研究组织 (CRO)

第 11 章：基于片段的药物发现市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美基于片段的药物发现主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲基于片段的药物发现主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区基于片段的药物发现主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按技术）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲基于片段的药物发现主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按技术）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲基于片段的药物发现主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 基于片段的药物发现产业

  • 竞争仪表板
  • 公司简介
    • Astex Pharmaceuticals, Inc.
    • BioSolveIT GmbH
    • Charles River Laboratories International, Inc.
    • ChemAxon Ltd.
    • Domainex Ltd.
    • Evotec SE
    • Heptares Therapeutics Ltd.
    • HitGen Ltd.
    • Iktos SAS
    • Merck KGaA
    • Plexxikon Inc.
    • Schrodinger, Inc.
    • Sygnature Discovery Limited
    • TCG Lifesciences Pvt. Ltd.
    • Vernalis Research Limited
    • WuXi AppTec Co., Ltd.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3981

REPORT HIGHLIGHT

Fragment-Based Drug Discovery Market size was valued at USD 798.90 million in 2023, expanding at a CAGR of 11.40% from 2024 to 2032.

Fragment-Based Drug Discovery (FBDD) refers to a method of drug discovery that involves the screening of small chemical fragments to identify potential lead compounds for drug development. The growing need for innovative therapeutics, particularly in the treatment of complex diseases like cancer and neurodegenerative disorders, has significantly propelled advancements in FBDD methodologies. Additionally, the increasing prevalence of chronic diseases is pushing pharmaceutical companies to explore novel approaches, as evidenced by the fact that over 60% of new drug candidates fail during clinical trials, underscoring the importance of early-stage discovery techniques. However, challenges such as high costs associated with fragment libraries and the complexity of fragment optimization can impede market growth. Opportunities lie in the integration of artificial intelligence and machine learning technologies to enhance fragment screening processes and improve the efficiency of drug discovery pipelines, thereby opening avenues for new therapeutic targets and increasing the success rate of drug development.

Fragment-Based Drug Discovery Market- Market Dynamics

Surging Chronic Disease Rates Propel Innovation in Fragment-Based Drug Discovery Market

The rising prevalence of chronic diseases, such as diabetes and cancer, is significantly fueling innovation in the Fragment-Based Drug Discovery (FBDD) Market, prompting pharmaceutical companies to seek more effective therapeutic solutions. According to the World Health Organization (WHO), chronic diseases account for 71% of all global deaths, underscoring the urgent need for innovative drug discovery methods. For instance, the American Cancer Society has reported that the number of cancer survivors in the U.S. is expected to rise to nearly 20 million by 2026, driving increased investment in advanced drug discovery techniques like FBDD. In response to these challenges, the National Institutes of Health (NIH) has allocated substantial funding toward research initiatives aimed at enhancing drug discovery processes and promoting collaborations among academic institutions, and pharmaceutical companies to foster groundbreaking therapies. This surge in chronic disease rates, coupled with government support and a focus on advanced methodologies, is set to accelerate the development of novel drugs through FBDD, paving the way for innovative treatments.

Fragment-Based Drug Discovery Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.40% over the forecast period (2024-2032)

Based on product type segmentation, Fragment Screening was predicted to show maximum market share in the year 2023

Based on Technology segmentation, X-ray crystallography was the leading type in 2023

Based on Application segmentation, Oncology was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Fragment-Based Drug Discovery Market- Segmentation Analysis:

The Global Fragment-Based Drug Discovery Market is segmented on the basis of Product Type, Technology, Application, End-User, and Region.

The market is divided into four categories based on product type: Fragment Screening, Fragment Libraries, Lead Optimization, and Biophysical Techniques. Fragment Screening holds the highest priority due to its critical role in identifying potential drug candidates, followed by Lead Optimization, essential for refining lead compounds. Fragment Libraries provide necessary resources, while Biophysical Techniques support validation and characterization.

The market is divided into four categories based on Technology: X-ray crystallography, Nuclear Magnetic Resonance (NMR) Spectroscopy, Surface Plasmon Resonance (SPR), and Isothermal Titration Calorimetry (ITC). X-ray crystallography ranks highest due to its precision in determining molecular structures, followed by Nuclear Magnetic Resonance (NMR) Spectroscopy for detailed insights into molecular interactions. Surface Plasmon Resonance (SPR) facilitates real-time binding studies, while Isothermal Titration Calorimetry (ITC) measures the thermodynamics of interactions.

Fragment-Based Drug Discovery Market- Geographical Insights

The Fragment-Based Drug Discovery (FBDD) Market exhibits distinct geographical dynamics, with North America leading the way, driven by robust research infrastructure and significant investments in biotechnology. In 2023, North America accounted for over 45% of the global market share, supported by initiatives such as the National Institutes of Health's (NIH) focus on advancing drug discovery technologies. Europe follows, with countries like the UK and Germany prioritizing FBDD in their pharmaceutical strategies, resulting in increased collaborations between academic institutions and industry players; notable funding of approximately €200 million was directed toward innovative drug discovery projects in 2022. The Asia-Pacific region is rapidly emerging, particularly in China and India, where growing pharmaceutical sectors and government initiatives are fostering research and development, as exemplified by the establishment of several FBDD-focused research centers. Latin America and the Middle East & Africa, though smaller markets are gradually expanding through increasing awareness of FBDD's benefits and strategic partnerships aimed at enhancing local drug discovery capabilities.

Fragment-Based Drug Discovery Market- Competitive Landscape:

The competitive landscape of the Fragment-Based Drug Discovery (FBDD) Market is marked by key players across various regions, each contributing uniquely to innovation and market growth. North America dominates the scene with companies like Amgen and Pfizer leading the charge; in 2023, Amgen reported a 30% increase in its drug discovery pipeline, heavily relying on FBDD techniques. In Europe, notable players such as AstraZeneca and Novartis are pushing forward, exemplified by AstraZeneca's commitment to invest €200 million in FBDD research initiatives aimed at targeting complex diseases. The Asia-Pacific region, represented by firms like WuXi AppTec and Takeda, is gaining traction; WuXi AppTec expanded its FBDD services in 2022, reflecting the rising demand for novel therapeutic approaches. Latin America is slowly emerging, with companies like Instituto Butantan exploring FBDD to address regional health challenges, while in the Middle East & Africa, local initiatives are fostering partnerships to enhance drug discovery capabilities, showcasing a collaborative approach to tackle unmet medical needs.

Recent Developments:

In February 2024, Researchers at the University at Buffalo developed a streamlined approach to fragment-based drug discovery, enabling earlier determination of the viability of fragment designs. This method optimizes the linking of fragments, potentially improving drug potency and reducing development costs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Astex Pharmaceuticals, Inc.
  • BioSolveIT GmbH
  • Charles River Laboratories International, Inc.
  • ChemAxon Ltd.
  • Domainex Ltd.
  • Evotec SE
  • Heptares Therapeutics Ltd.
  • HitGen Ltd.
  • Iktos SAS
  • Merck KGaA
  • Plexxikon Inc.
  • Schrodinger, Inc.
  • Sygnature Discovery Limited
  • TCG Lifesciences Pvt. Ltd.
  • Vernalis Research Limited
  • WuXi AppTec Co., Ltd.
  • Others

GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Fragment Screening
  • Fragment Libraries
  • Lead Optimization
  • Biophysical Techniques

GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • X-Ray Crystallography
  • Nuclear Magnetic Resonance (NMR) Spectroscopy
  • Surface Plasmon Resonance (SPR)
  • Isothermal Titration Calorimetry (ITC)

GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Neurological Disorders

GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Fragment-Based Drug Discovery Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Fragment-Based Drug Discovery Market Snippet by Product Type
    • 2.1.2. Fragment-Based Drug Discovery Market Snippet by Technology
    • 2.1.3. Fragment-Based Drug Discovery Market Snippet by Application
    • 2.1.4. Fragment-Based Drug Discovery Market Snippet by End-User
    • 2.1.5. Fragment-Based Drug Discovery Market Snippet by Country
    • 2.1.6. Fragment-Based Drug Discovery Market Snippet by Region
  • 2.2. Competitive Insights

3. Fragment-Based Drug Discovery Key Market Trends

  • 3.1. Fragment-Based Drug Discovery Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Fragment-Based Drug Discovery Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Fragment-Based Drug Discovery Market Opportunities
  • 3.4. Fragment-Based Drug Discovery Market Future Trends

4. Fragment-Based Drug Discovery Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Fragment-Based Drug Discovery Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Fragment-Based Drug Discovery Market Landscape

  • 6.1. Fragment-Based Drug Discovery Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Fragment-Based Drug Discovery Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Fragment Screening
    • 7.1.3. Fragment Libraries
    • 7.1.4. Lead Optimization
    • 7.1.5. Biophysical Techniques

8. Fragment-Based Drug Discovery Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2. X-Ray Crystallography
    • 8.1.3. Nuclear Magnetic Resonance (NMR) Spectroscopy
    • 8.1.4. Surface Plasmon Resonance (SPR)
    • 8.1.5. Isothermal Titration Calorimetry (ITC)

9. Fragment-Based Drug Discovery Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Oncology
    • 9.1.3. Infectious Diseases
    • 9.1.4. Cardiovascular Diseases
    • 9.1.5. Neurological Disorders

10. Fragment-Based Drug Discovery Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Biotechnology Companies
    • 10.1.4. Academic & Research Institutes
    • 10.1.5. Contract Research Organizations (CROs)

11. Fragment-Based Drug Discovery Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Fragment-Based Drug Discovery Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Fragment-Based Drug Discovery Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Fragment-Based Drug Discovery Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Fragment-Based Drug Discovery Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Fragment-Based Drug Discovery Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Fragment-Based Drug Discovery Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Astex Pharmaceuticals, Inc.
    • 12.2.2. BioSolveIT GmbH
    • 12.2.3. Charles River Laboratories International, Inc.
    • 12.2.4. ChemAxon Ltd.
    • 12.2.5. Domainex Ltd.
    • 12.2.6. Evotec SE
    • 12.2.7. Heptares Therapeutics Ltd.
    • 12.2.8. HitGen Ltd.
    • 12.2.9. Iktos SAS
    • 12.2.10. Merck KGaA
    • 12.2.11. Plexxikon Inc.
    • 12.2.12. Schrodinger, Inc.
    • 12.2.13. Sygnature Discovery Limited
    • 12.2.14. TCG Lifesciences Pvt. Ltd.
    • 12.2.15. Vernalis Research Limited
    • 12.2.16. WuXi AppTec Co., Ltd.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us